Yüklüyor......
Efficacy and Safety of Atrasentan in Patients With Cardiovascular Risk and Early Atherosclerosis
Endothelin plays an important role in the pathogenesis of atherosclerosis. The aim of the study was to evaluate the safety and hemodynamic and metabolic responses to 6 months treatment with atrasentan, the selective endothelin-A receptor antagonist. Seventy-two patients with multiple cardiovascular...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2675066/ https://ncbi.nlm.nih.gov/pubmed/18695150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.108.113068 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|